147 related articles for article (PubMed ID: 33960140)
1. Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014.
Yu XQ; Dasgupta P; Kahn C; Kou K; Cramb S; Baade P
Cancer Med; 2021 Jun; 10(11):3524-3532. PubMed ID: 33960140
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD
Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423
[TBL] [Abstract][Full Text] [Related]
3. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
4. Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
Naylor KL; Kim SJ; McArthur E; Garg AX; McCallum MK; Knoll GA
Am J Kidney Dis; 2019 Jun; 73(6):765-776. PubMed ID: 30738630
[TBL] [Abstract][Full Text] [Related]
5. Quantifying the absolute number of cancer deaths that would be avoided if cancers were diagnosed prior to progressing to distant metastasis, New South Wales, Australia 1985-2014.
Yu XQ; Dasgupta P; Baade P
Int J Cancer; 2022 Jun; 150(11):1760-1769. PubMed ID: 35037243
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach.
Baade PD; Youlden DR; Andersson TM; Youl PH; Walpole ET; Kimlin MG; Aitken JF; Biggar RJ
Cancer Causes Control; 2016 Aug; 27(8):955-64. PubMed ID: 27306518
[TBL] [Abstract][Full Text] [Related]
7. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
Howlader N; Mariotto AB; Woloshin S; Schwartz LM
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):255-64. PubMed ID: 25417239
[TBL] [Abstract][Full Text] [Related]
8. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
9. Trends in survival and excess risk of death after diagnosis of cancer in 1980-1996 in New South Wales, Australia.
Yu XQ; O'Connell DL; Gibberd RW; Coates AS; Armstrong BK
Int J Cancer; 2006 Aug; 119(4):894-900. PubMed ID: 16550595
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
[TBL] [Abstract][Full Text] [Related]
12. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
Hu CY; Xing Y; Cormier JN; Chang GJ
Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites.
Yu XQ; O'Connell DL; Forman D
Br J Cancer; 2004 Nov; 91(9):1663-5. PubMed ID: 15477869
[TBL] [Abstract][Full Text] [Related]
14. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales.
Tervonen HE; Walton R; You H; Baker D; Roder D; Currow D; Aranda S
BMC Cancer; 2017 Jun; 17(1):398. PubMed ID: 28577351
[TBL] [Abstract][Full Text] [Related]
15. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
[TBL] [Abstract][Full Text] [Related]
16. Conditional survival of cancer patients: an Australian perspective.
Yu XQ; Baade PD; O'Connell DL
BMC Cancer; 2012 Oct; 12():460. PubMed ID: 23043308
[TBL] [Abstract][Full Text] [Related]
17. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
Wright CM; Nowak AK; Halkett G; Moorin RE
BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
[TBL] [Abstract][Full Text] [Related]
18. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
Dasgupta P; Aitken JF; Pyke C; Baade PD
Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
[TBL] [Abstract][Full Text] [Related]
19. Conditional crude probabilities of death for English cancer patients.
Wong KF; Lambert PC; Mozumder SI; Broggio J; Rutherford MJ
Br J Cancer; 2019 Nov; 121(10):883-889. PubMed ID: 31601960
[TBL] [Abstract][Full Text] [Related]
20. Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia.
Lawrance S; Bui C; Mahindra V; Arcorace M; Cooke-Yarborough C
BMC Cancer; 2019 Aug; 19(1):850. PubMed ID: 31462255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
